Global Drug of Abuse Testing Market Projected To Reach 4.1 Billion USD By 2022

Date: 2018-03-08

Drug of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Drug testing is used so that a person may receive appropriate medical treatment or be screened for or monitored for illegal drug use.

The growing population, rising incidence of drug-related death and accidents, and the increase in trafficking of illegal drugs around the world are the key contributors to drive the growth for the Drug of Abuse Testing market, according to a brand new research, the global Drug of Abuse Testing market is projected to reach 4.1 billion USD by 2022, at a CAGR of 9.1% from 2018-2022.

Base on applications, the urine testing segment held the largest share which accounted for 29.6% of market share in 2017, the hospital is the most frequent place where the testing services take place, base on drugs, the Cannabis emerged as the largest drug type segment and the opioids segment is anticipated to witness fastest growth over the next 5 years

In terms of geography, North America is consider as the mature market in Drug of Abuse Testing especially in Cannabis products, according to research, the North America is expecting to remain the largest market for the clinical Drug of Abuse Testing. 

However, the Asia Pacific is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical Drug of Abuse Testing procedures across India, China, and Japan; and rising incidences of infectious diseases.

Global top manufacturers operating in Drug of Abuse Testing Market are Siemens HealthcareAG,, F. Hoffmann-La Roche Ltd., Millipore Sigma, Danaher Corporation, Alere Inc., Abbott Laboratories, Drägerwerk AG & Co. KGAA, Express Diagnostics Int’l, Inc. Shimadzu Corporation, Waters Corporation, bioMérieux SA, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Psychemedics Corporation, Sonic Healthcare Ltd. Thermo Fisher Scientific Inc., and Bio-Rad Laboratories among others.

Global Drug of Abuse Testing market share by region as following:

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample